首页 > 最新文献

Annals of Saudi medicine最新文献

英文 中文
Brucellosis in Omani children: a multicenter experience over 15 years. 阿曼儿童布鲁氏菌病:15 年来的多中心经验。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.380
Lamees Al Sawafi, Amal Al Tai, Mohammed Al Reesi, Mahmood Al Subhi, Muna Al Busaidi, Sanaa Al Abri, Badria Al Waili

Background: Brucellosis, a common zoonotic disease worldwide, can lead to serious complications in humans. In Oman, the disease occurs most often in the south, but is increasing in the north.

Objectives: Describe brucellosis in children in the Northern Governorate in Oman.

Design: Retrospective, observational.

Settings: Hospitals in the Northern Governorate in Oman.

Patients and methods: We collected data on the demographics, distribution, common clinical presentations, risk factors, laboratory findings, therapy, and complications of confirmed cases of brucellosis. We included all brucellosis cases up to the age of 13 years at the Child Health Department in Royal, Suhar, Al Rustaq and Nizwa Hospitals over a 15-year period.

Main outcome measures: Descriptive findings of brucellosis.

Sample size: 57 confirmed cases.

Results: The 57 confirmed cases of Brucella had a mean age of 6 years. Most of the cases were from Dhakhiliya 21 (36.8%) and Batinah 18 (31.6%). Consumption of raw milk was documented in 75% and 41% had animal contact. From 2010, there was a marked rise of the cases with a maximum rise was noticed in 2019 with a total of 10 cases. The main clinical manifestations were fever (92%, n=52), arthritis (44%, n=25), which involved mainly knees and hips. Forty-two had bacteremia, 41% anemia, 10% osteomyelitis/septic arthritis, one case with congenital brucellosis and one case neurobrucellosis (1.8%). Forty cases had positive serology results of which 19 had positive cultures. Most cases had received cotrimoxazole and rifampin as the primary treatment regimen 22 (40%). Four patients relapsed (7%) after treatment completion.

Conclusion: This study showed the distribution and clinical characteristics of brucellosis in different regions in the Northern Governorate in Oman. Although the numbers of cases remained low, the gradual increase is concerning for public health and preventive strategies. Further studies are needed to compare this data with the Southern region.

Limitation: Retrospective study with small sample size.

背景:布鲁氏菌病是一种全球常见的人畜共患病,可导致人类出现严重并发症。在阿曼,该病多发于南部地区,但在北部地区的发病率正在上升:描述阿曼北部省儿童中的布鲁氏菌病:设计:回顾性观察:背景:阿曼北部省的医院:我们收集了布鲁氏菌病确诊病例的人口统计学、分布、常见临床表现、风险因素、实验室检查结果、治疗和并发症等方面的数据。我们收集了15年间皇家医院、苏哈尔医院、鲁斯塔克医院和尼兹瓦医院儿童健康部13岁以下的所有布鲁氏菌病病例:样本量:57 例确诊病例:结果:57 例布鲁氏菌确诊病例的平均年龄为 6 岁。大多数病例来自达希利亚(Dhakhiliya)21 例(36.8%)和巴蒂纳(Batinah)18 例(31.6%)。据记录,75%的病例食用生牛奶,41%的病例与动物有过接触。从 2010 年开始,病例数明显上升,在 2019 年达到最高峰,共有 10 例。主要临床表现为发热(92%,n=52)、关节炎(44%,n=25),主要累及膝关节和髋关节。42例出现菌血症,41%贫血,10%骨髓炎/化脓性关节炎,1例先天性布鲁氏菌病,1例神经性布鲁氏菌病(1.8%)。40 个病例的血清学结果呈阳性,其中 19 个病例的培养结果呈阳性。大多数病例的主要治疗方案是复方新诺明和利福平 22 例(40%)。4名患者在治疗结束后复发(7%):这项研究显示了布鲁氏菌病在阿曼北部省不同地区的分布情况和临床特征。尽管病例数量仍然较少,但其逐渐增加的趋势对公共卫生和预防策略而言令人担忧。需要进一步开展研究,将这一数据与南部地区的数据进行比较:局限性:回顾性研究,样本量较小。
{"title":"Brucellosis in Omani children: a multicenter experience over 15 years.","authors":"Lamees Al Sawafi, Amal Al Tai, Mohammed Al Reesi, Mahmood Al Subhi, Muna Al Busaidi, Sanaa Al Abri, Badria Al Waili","doi":"10.5144/0256-4947.2023.380","DOIUrl":"10.5144/0256-4947.2023.380","url":null,"abstract":"<p><strong>Background: </strong>Brucellosis, a common zoonotic disease worldwide, can lead to serious complications in humans. In Oman, the disease occurs most often in the south, but is increasing in the north.</p><p><strong>Objectives: </strong>Describe brucellosis in children in the Northern Governorate in Oman.</p><p><strong>Design: </strong>Retrospective, observational.</p><p><strong>Settings: </strong>Hospitals in the Northern Governorate in Oman.</p><p><strong>Patients and methods: </strong>We collected data on the demographics, distribution, common clinical presentations, risk factors, laboratory findings, therapy, and complications of confirmed cases of brucellosis. We included all brucellosis cases up to the age of 13 years at the Child Health Department in Royal, Suhar, Al Rustaq and Nizwa Hospitals over a 15-year period.</p><p><strong>Main outcome measures: </strong>Descriptive findings of brucellosis.</p><p><strong>Sample size: </strong>57 confirmed cases.</p><p><strong>Results: </strong>The 57 confirmed cases of Brucella had a mean age of 6 years. Most of the cases were from Dhakhiliya 21 (36.8%) and Batinah 18 (31.6%). Consumption of raw milk was documented in 75% and 41% had animal contact. From 2010, there was a marked rise of the cases with a maximum rise was noticed in 2019 with a total of 10 cases. The main clinical manifestations were fever (92%, n=52), arthritis (44%, n=25), which involved mainly knees and hips. Forty-two had bacteremia, 41% anemia, 10% osteomyelitis/septic arthritis, one case with congenital brucellosis and one case neurobrucellosis (1.8%). Forty cases had positive serology results of which 19 had positive cultures. Most cases had received cotrimoxazole and rifampin as the primary treatment regimen 22 (40%). Four patients relapsed (7%) after treatment completion.</p><p><strong>Conclusion: </strong>This study showed the distribution and clinical characteristics of brucellosis in different regions in the Northern Governorate in Oman. Although the numbers of cases remained low, the gradual increase is concerning for public health and preventive strategies. Further studies are needed to compare this data with the Southern region.</p><p><strong>Limitation: </strong>Retrospective study with small sample size.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138815738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ceftazidime-avibactam use for the treatment of OXA-48- and/or New Delhi metallo-β-lactamase-producing Enterobacterales in cancer patients: a retrospective observational study. 使用头孢唑肟-阿维巴坦治疗癌症患者中产 OXA-48 和/或新德里金属-β-内酰胺酶肠杆菌:一项回顾性观察研究。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.373
Ahlam Alghamdi, Hajar AlQahtani, Sara Albilal, Maram Mater Almutairi, Nouf Alobaidallah, Linah Alghamdi, Amal Alfayez, Thamer Almangour, Ahmed Al-Jedai

Background: Infection is the second-leading cause of death among cancer patients, but there have been few studies on the effectiveness of novel antimicrobial agents to treat carbapenem-resistant Enterobacterales in cancer patients.

Objective: Evaluate the mortality and clinical outcomes of ceftazi-dime-avibactam for OXA-48- and/or New Delhi metallo-β-lactamase (NDM)-producing Enterobacterales infection in cancer patients.

Design: Retrospective observational cohort study.

Setting: Tertiary academic medical center in Riyadh, Saudi Arabia.

Subjects and methods: This study included patients who had cancer and received ceftazidime-avibactam for at least 72 hours for infections caused by OXA-48- and/or NDM-producing Enterobacterales. We excluded patients who died within 72 hours of treatment, patients with polymicrobial infections, and patients who did not receive appropriate antimicrobial therapy.

Main outcomes and measures: Primary outcomes were 30-day mortality and hospital mortality. Secondary outcomes included clinical cure, relapse, and reinfection.

Sample size: 32 cancer patients.

Results: The 30-day mortality among all patients was 15/32 (47%), clinical cure was achieved in 19/32 (59%) of the patients, and the relapse and reinfection rates were 2/19 (10.5%) and 4/17 (23.5%), respectively.

Conclusion: This is the largest study to evaluate clinical outcomes associated with infections caused by OXA-48- and/or NDM-producing Enterobacterales in cancer patients. The mortality rate remains high; however, ceftazidime-avibactam is an encouraging alternative for treating severe infections in cancer patients.

Limitations: Small sample size and single center.

背景:感染是癌症患者的第二大死因,但有关新型抗菌药物治疗癌症患者耐碳青霉烯类肠杆菌效果的研究却很少:评估头孢他啶-阿维巴坦治疗癌症患者中产OXA-48和/或新德里金属-β-内酰胺酶(NDM)肠杆菌感染的死亡率和临床疗效:设计:回顾性观察队列研究:研究对象和方法:研究对象包括因感染 OXA-48 和/或 NDM 产肠杆菌而接受头孢他啶-阿维巴坦治疗至少 72 小时的癌症患者。我们排除了治疗后72小时内死亡的患者、多微生物感染患者以及未接受适当抗菌治疗的患者:主要结果和衡量标准:主要结果是 30 天死亡率和住院死亡率。次要结果包括临床治愈、复发和再感染:所有患者的 30 天死亡率为 15/32(47%),19/32(59%)的患者达到临床治愈,复发率和再感染率分别为 2/19(10.5%)和 4/17(23.5%):结论:这是对癌症患者因产OXA-48和/或NDM肠杆菌引起的感染相关临床结果进行评估的最大规模研究。死亡率仍然很高;不过,头孢他啶-阿维巴坦是治疗癌症患者严重感染的令人鼓舞的替代方案:局限性:样本量小,且为单中心研究。
{"title":"Ceftazidime-avibactam use for the treatment of OXA-48- and/or New Delhi metallo-β-lactamase-producing <i>Enterobacterales</i> in cancer patients: a retrospective observational study.","authors":"Ahlam Alghamdi, Hajar AlQahtani, Sara Albilal, Maram Mater Almutairi, Nouf Alobaidallah, Linah Alghamdi, Amal Alfayez, Thamer Almangour, Ahmed Al-Jedai","doi":"10.5144/0256-4947.2023.373","DOIUrl":"10.5144/0256-4947.2023.373","url":null,"abstract":"<p><strong>Background: </strong>Infection is the second-leading cause of death among cancer patients, but there have been few studies on the effectiveness of novel antimicrobial agents to treat carbapenem-resistant <i>Enterobacterales</i> in cancer patients.</p><p><strong>Objective: </strong>Evaluate the mortality and clinical outcomes of ceftazi-dime-avibactam for OXA-48- and/or New Delhi metallo-β-lactamase (NDM)-producing <i>Enterobacterales</i> infection in cancer patients.</p><p><strong>Design: </strong>Retrospective observational cohort study.</p><p><strong>Setting: </strong>Tertiary academic medical center in Riyadh, Saudi Arabia.</p><p><strong>Subjects and methods: </strong>This study included patients who had cancer and received ceftazidime-avibactam for at least 72 hours for infections caused by OXA-48- and/or NDM-producing <i>Enterobacterales</i>. We excluded patients who died within 72 hours of treatment, patients with polymicrobial infections, and patients who did not receive appropriate antimicrobial therapy.</p><p><strong>Main outcomes and measures: </strong>Primary outcomes were 30-day mortality and hospital mortality. Secondary outcomes included clinical cure, relapse, and reinfection.</p><p><strong>Sample size: </strong>32 cancer patients.</p><p><strong>Results: </strong>The 30-day mortality among all patients was 15/32 (47%), clinical cure was achieved in 19/32 (59%) of the patients, and the relapse and reinfection rates were 2/19 (10.5%) and 4/17 (23.5%), respectively.</p><p><strong>Conclusion: </strong>This is the largest study to evaluate clinical outcomes associated with infections caused by OXA-48- and/or NDM-producing <i>Enterobacterales</i> in cancer patients. The mortality rate remains high; however, ceftazidime-avibactam is an encouraging alternative for treating severe infections in cancer patients.</p><p><strong>Limitations: </strong>Small sample size and single center.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with 30-day mortality and morbidity in patients undergoing emergency colorectal surgery. 急诊结肠直肠手术患者 30 天死亡率和发病率的相关因素。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.364
Nahar A Alselaim, Muhannad Abdulrahman Alsemari, Mesnad Alyabsi, Abrar M Al-Mutairi

Background: The 30-day period following emergency colorectal surgery (ECRS) is associated with high mortality and morbidity. There is a lack of data assessing factors associated with outcomes of ECRS in the Saudi population.

Objectives: Assess factors associated with 30-day postoperative mortality and complications following ECRS.

Design: Retrospective cohort study.

Setting: Single tertiary care center, Riyadh, Saudi Arabia.

Patients and methods: Demographic characteristics (age, sex, diagnosis, American Society of Anesthesiologists classification, pre-operative septic state, smoking, and comorbidities), operative characteristics (urgency, diverting ostomy, and procedure performed), and postoperative characteristics (length of stay, 30-day mortality, intensive care unit [ICU] admission, ICU length of stay, surgical site infection [SSI], readmission, reoperation, and complications) were collected from electronic medical records. Univariate logistic regression was used to evaluate association with the outcome measures (30-day mortality and postoperative complications). Multivariate logistic regression was applied to evaluate independent variables.

Main outcome measure: Thirty-day postoperative mortality and morbidity.

Sample size: 241 patients.

Results: Among 241 patients, 145 (60.2%) were men, and 80 (33.2%) patients were between 50-64 years of age. The most common indication for surgery was malignancy 138 (57%). The overall complication rate was 26.6% and the 30-day mortality rate was 11.2%. Left hemicolectomy was the most commonly performed procedure, performed in 69 (28.6%) patients. Patients between the age of 65-74 had an increased odds of death within 30 days (OR 5.25 [95% CI 1.03-26.5]) on univariate analysis. Preoperative sepsis was associated with a fourfold increase in the likelihood of 30-day mortality (OR 4.44, 95% CI 1.21-16.24, P=.024) on multivariate analysis. The likelihood of hospital re-admission increased by fivefold in patients who developed a postoperative complication (OR 5.33, 95% CI 1.30-21.78, P=.02).

Conclusion: Preoperative sepsis was independently associated with 30-day mortality in patients undergoing ECRS, while the likelihood of hospital readmission increased in patients with postoperative complications. Expeditious control of sepsis in the emergency surgical setting by both surgical and medical interventions may reduce the likelihood of postoperative mortality. Establishing discharge protocols for postoperative ECRS patients is advocated.

Limitations: Retrospective design, small sample size, and single setting.

背景:急诊结直肠手术(ECRS)后的 30 天内死亡率和发病率都很高。在沙特人口中,缺乏评估与 ECRS 结果相关因素的数据:评估 ECRS 术后 30 天死亡率和并发症的相关因素:设计:回顾性队列研究:地点:沙特阿拉伯利雅得,一家三级医疗中心:从电子病历中收集人口统计学特征(年龄、性别、诊断、美国麻醉医师协会分类、术前脓毒血症状态、吸烟和合并症)、手术特征(紧急程度、分流造口和所实施的手术)和术后特征(住院时间、30 天死亡率、入住重症监护室 [ICU]、ICU 住院时间、手术部位感染 [SSI]、再次入院、再次手术和并发症)。采用单变量逻辑回归评估与结果指标(30 天死亡率和术后并发症)的相关性。主要结果指标:术后 30 天死亡率和发病率:241名患者中,145名(60.2%)为男性,80名(33.2%)年龄在50-64岁之间。最常见的手术指征是恶性肿瘤 138 例(57%)。总体并发症发生率为 26.6%,30 天死亡率为 11.2%。左半结肠切除术是最常见的手术,有 69 例(28.6%)患者接受了该手术。经单变量分析,65-74 岁患者在 30 天内死亡的几率增加(OR 5.25 [95% CI 1.03-26.5])。在多变量分析中,术前脓毒症导致 30 天内死亡的可能性增加了四倍(OR 4.44,95% CI 1.21-16.24,P=0.024)。术后出现并发症的患者再次入院的可能性增加了五倍(OR 5.33,95% CI 1.30-21.78,P=.02):结论:术前败血症与接受 ECRS 患者的 30 天死亡率密切相关,而术后出现并发症的患者再次入院的可能性增加。在急诊手术环境中通过手术和药物干预迅速控制脓毒症可降低术后死亡率。建议为ECRS术后患者制定出院方案:局限性:回顾性设计、样本量小、环境单一。
{"title":"Factors associated with 30-day mortality and morbidity in patients undergoing emergency colorectal surgery.","authors":"Nahar A Alselaim, Muhannad Abdulrahman Alsemari, Mesnad Alyabsi, Abrar M Al-Mutairi","doi":"10.5144/0256-4947.2023.364","DOIUrl":"10.5144/0256-4947.2023.364","url":null,"abstract":"<p><strong>Background: </strong>The 30-day period following emergency colorectal surgery (ECRS) is associated with high mortality and morbidity. There is a lack of data assessing factors associated with outcomes of ECRS in the Saudi population.</p><p><strong>Objectives: </strong>Assess factors associated with 30-day postoperative mortality and complications following ECRS.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Single tertiary care center, Riyadh, Saudi Arabia.</p><p><strong>Patients and methods: </strong>Demographic characteristics (age, sex, diagnosis, American Society of Anesthesiologists classification, pre-operative septic state, smoking, and comorbidities), operative characteristics (urgency, diverting ostomy, and procedure performed), and postoperative characteristics (length of stay, 30-day mortality, intensive care unit [ICU] admission, ICU length of stay, surgical site infection [SSI], readmission, reoperation, and complications) were collected from electronic medical records. Univariate logistic regression was used to evaluate association with the outcome measures (30-day mortality and postoperative complications). Multivariate logistic regression was applied to evaluate independent variables.</p><p><strong>Main outcome measure: </strong>Thirty-day postoperative mortality and morbidity.</p><p><strong>Sample size: </strong>241 patients.</p><p><strong>Results: </strong>Among 241 patients, 145 (60.2%) were men, and 80 (33.2%) patients were between 50-64 years of age. The most common indication for surgery was malignancy 138 (57%). The overall complication rate was 26.6% and the 30-day mortality rate was 11.2%. Left hemicolectomy was the most commonly performed procedure, performed in 69 (28.6%) patients. Patients between the age of 65-74 had an increased odds of death within 30 days (OR 5.25 [95% CI 1.03-26.5]) on univariate analysis. Preoperative sepsis was associated with a fourfold increase in the likelihood of 30-day mortality (OR 4.44, 95% CI 1.21-16.24, <i>P</i>=.024) on multivariate analysis. The likelihood of hospital re-admission increased by fivefold in patients who developed a postoperative complication (OR 5.33, 95% CI 1.30-21.78, <i>P</i>=.02).</p><p><strong>Conclusion: </strong>Preoperative sepsis was independently associated with 30-day mortality in patients undergoing ECRS, while the likelihood of hospital readmission increased in patients with postoperative complications. Expeditious control of sepsis in the emergency surgical setting by both surgical and medical interventions may reduce the likelihood of postoperative mortality. Establishing discharge protocols for postoperative ECRS patients is advocated.</p><p><strong>Limitations: </strong>Retrospective design, small sample size, and single setting.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical outcomes and stoma-related complications in inflammatory bowel disease in Saudi Arabia: a retrospective study. 沙特阿拉伯炎症性肠病的手术效果和与造口相关的并发症:一项回顾性研究。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.386
Thamer A Bin Traiki, Sulaiman A Alshammari, Mansoor A Abdulla, Fayez G Aldarsouni, Noura S Alhassan, Maha-Hamdien Abdullah, Awadh Alqahtani, Khayal A Alkhayal

Background: The prevalence of inflammatory bowel diseases (IBD), Crohn's (C) and ulcerative colitis (UC) has increased in Saudi Arabia during the past decade. Even though medical treatment is first-line therapy, most patients require surgery during the course of the disease. Stoma creation complications in IBD are underreported in the literature of the Middle East and especially in Saudi Arabia.

Objectives: Report the postoperative, stoma and peristomal complications following stoma creation in (C) versus UC.

Design: Retrospective cohort study.

Settings: Tertiary care center.

Patients and methods: Patients with IBD who underwent stoma creation for either UC or CD between August 2015 and July 2020 were included. The diseases were compared to assess their characteristics and association to postoperative, stoma and peristomal complications. All complications were reported over a 90-day duration from the surgery. Patients younger than 14 years of age were excluded.

Main outcome measures: Postoperative complications, stoma and peristomal complications in IBD patients who underwent stoma creation.

Sample size: 50.

Results: Of 50 IBD patients underwent stoma creation, 32 patients (64%) were diagnosed with CD and 18 patients (36%) with UC. Most of the procedures in both groups were laparoscopic and elective. Low BMI and serum albumin were more prevalent in the CD group. Postoperative complications were higher in the CD patients compared to the UC patients (CD 40.6% vs UC 11.1%, P=.028) with the most common complication being abdominal collection[a]. Stoma complications were comparable between the two groups (UC 16.7% vs CD 15.6%). However, peristomal complications were higher clinically in UC patients in comparison with the CD patients (UC 61.1% vs CD 37.5% P=.095) with the most common complication being skin excoriation (UC 44.4% vs CD 37.5%).

Conclusions: CD has significantly higher postoperative complications compared to UC. Peristomal complications were high in both groups and had a negative impact on quality of life. Therefore, comprehensive stoma education and regular outpatient follow ups are recommended to improve the overall outcomes.

Limitations: Retrospective and conducted in one academic institution with a small sample size.

背景:过去十年间,沙特阿拉伯的炎症性肠病(IBD)、克罗恩病(Crohn's)和溃疡性结肠炎(UC)发病率有所上升。尽管药物治疗是一线疗法,但大多数患者在病程中仍需要手术治疗。在中东地区,尤其是沙特阿拉伯,有关 IBD 造口并发症的文献报道不足:报告造口术(C)与UC术后的术后、造口和造口周围并发症:设计:回顾性队列研究:患者和方法:接受造口术的 IBD 患者:纳入2015年8月至2020年7月期间因UC或CD而接受造口术的IBD患者。对这些疾病进行比较,以评估其特征以及与术后、造口和肛周并发症的关联。所有并发症均在手术后 90 天内报告。排除了年龄小于14岁的患者:主要结果指标:接受造口术的IBD患者的术后并发症、造口和造口周围并发症:结果:在50名接受造口术的IBD患者中,32名患者(64%)被诊断为CD,18名患者(36%)被诊断为UC。两组患者中的大多数手术都是腹腔镜手术和择期手术。CD 组患者的体重指数和血清白蛋白较低。与 UC 患者相比,CD 患者的术后并发症更高(CD 40.6% vs UC 11.1%,P=.028),最常见的并发症是腹腔积液[a]。两组造口并发症的发生率相当(UC 16.7% vs CD 15.6%)。然而,UC 患者的造口周围临床并发症高于 CD 患者(UC 61.1% vs CD 37.5%,P=.095),最常见的并发症是皮肤切除(UC 44.4% vs CD 37.5%):结论:CD的术后并发症明显高于UC。两组患者的造口周围并发症都很高,对生活质量产生了负面影响。因此,建议进行全面的造口教育和定期的门诊随访,以改善整体疗效:回顾性研究,在一家学术机构进行,样本量较小。
{"title":"Surgical outcomes and stoma-related complications in inflammatory bowel disease in Saudi Arabia: a retrospective study.","authors":"Thamer A Bin Traiki, Sulaiman A Alshammari, Mansoor A Abdulla, Fayez G Aldarsouni, Noura S Alhassan, Maha-Hamdien Abdullah, Awadh Alqahtani, Khayal A Alkhayal","doi":"10.5144/0256-4947.2023.386","DOIUrl":"10.5144/0256-4947.2023.386","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of inflammatory bowel diseases (IBD), Crohn's (C) and ulcerative colitis (UC) has increased in Saudi Arabia during the past decade. Even though medical treatment is first-line therapy, most patients require surgery during the course of the disease. Stoma creation complications in IBD are underreported in the literature of the Middle East and especially in Saudi Arabia.</p><p><strong>Objectives: </strong>Report the postoperative, stoma and peristomal complications following stoma creation in (C) versus UC.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Settings: </strong>Tertiary care center.</p><p><strong>Patients and methods: </strong>Patients with IBD who underwent stoma creation for either UC or CD between August 2015 and July 2020 were included. The diseases were compared to assess their characteristics and association to postoperative, stoma and peristomal complications. All complications were reported over a 90-day duration from the surgery. Patients younger than 14 years of age were excluded.</p><p><strong>Main outcome measures: </strong>Postoperative complications, stoma and peristomal complications in IBD patients who underwent stoma creation.</p><p><strong>Sample size: </strong>50.</p><p><strong>Results: </strong>Of 50 IBD patients underwent stoma creation, 32 patients (64%) were diagnosed with CD and 18 patients (36%) with UC. Most of the procedures in both groups were laparoscopic and elective. Low BMI and serum albumin were more prevalent in the CD group. Postoperative complications were higher in the CD patients compared to the UC patients (CD 40.6% vs UC 11.1%, <i>P</i>=.028) with the most common complication being abdominal collection[a]. Stoma complications were comparable between the two groups (UC 16.7% vs CD 15.6%). However, peristomal complications were higher clinically in UC patients in comparison with the CD patients (UC 61.1% vs CD 37.5% <i>P</i>=.095) with the most common complication being skin excoriation (UC 44.4% vs CD 37.5%).</p><p><strong>Conclusions: </strong>CD has significantly higher postoperative complications compared to UC. Peristomal complications were high in both groups and had a negative impact on quality of life. Therefore, comprehensive stoma education and regular outpatient follow ups are recommended to improve the overall outcomes.</p><p><strong>Limitations: </strong>Retrospective and conducted in one academic institution with a small sample size.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of neonatal severe hyperparathyroidism. 新生儿严重甲状旁腺功能亢进症的外科治疗。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.01.11.1200
Saud Alshanafey, Sabreen Maqbol, Ali AlAmeer, Faiqa Ahmad, Abdullah Al-Ashwal

Background: Neonatal severe hyperparathyroidism (NSHPT) is a rare disease that can be lethal. Most patients require parathyroidectomy.

Objective: Report experience in managing this severe disease.

Design: Retrospective chart review of case series.

Setting: Tertiary health care center.

Patients and methods: We reviewed data on patients managed for NSHPT from June 2001 to January 2023. Demographic, clinical, and follow-up data were collected, and descriptive data were generated.

Main outcome measures: Pre- and postoperative levels of parathyroid hormone (PTH) and serum calcium, and effect of autotransplantation.

Sample size: 19.

Results: The 13 males and 6 females had a a mean age of 46 days at referral. The mean preoperative parathyroid hormone (PTH) and serum calcium levels were 996 ng/L and 4.54 mmol/L, respectively. Twelve patients underwent ultrasonography preoperatively. Of these, six had prominent glands, while no glands were seen in the other six. A Sestamibi scan was done for 15 patients, of which nine showed negative results and six showed positive results, with three glands observed in the neck and three in the sublingual area. Nineteen patients underwent renal ultrasonography, with nine showing nephrocalcinosis. The mean age at surgery was 5.2 months. Total parathyroidectomy (four glands) was performed in 17 patients, and 15 underwent concurrent auto-transplantation. One patient had three glands removed, in addition to auto-transplantation. Another underwent single gland excision as a redo-surgery after previous surgery elsewhere. The mean postoperative follow-up duration was 6 years. The mean postoperative PTH and calcium levels were 25 ng/L and 1.64 mmol/L, respectively. Ultimately, all the patients were required to initiate calcium and vitamin D supplements, except for two patients who had undergone auto-transplantation. Molecular genetic screening of the calcium-sensing receptor gene reported likely pathogenic/pathogenic mutations in 16 of 19 patients (13 were homozygous, two were heterozygous, one was negative, and data was unavailable for the remaining three patients).

Conclusions: Surgical treatment of NSHPT is effective. Preoperative radiological localization studies did not impact the treatment plan. Auto-transplantation proved ineffective in maintaining independence from medical supplements.

Limitations: The retrospective nature of the study may imply inaccuracybut since the data are gathered from electronic medical records, we believe it is highly accurate. The small sample size limits generalizability.

背景:新生儿严重甲状旁腺功能亢进症(NSHPT)是一种罕见的致命疾病。大多数患者需要甲状旁腺切除术。目的:报告治疗这种严重疾病的经验。设计:病例系列回顾性图表回顾。设置:三级医疗保健中心。患者和方法:我们回顾了2001年6月至2023年1月接受NSHPT治疗的患者的数据。收集人口统计学、临床和随访数据,并生成描述性数据。主要观察指标:术前和术后甲状旁腺激素(PTH)和血清钙水平,以及自体移植的效果。样本量:19结果:13名男性和6名女性在转诊时的平均年龄为46天。术前平均甲状旁腺激素(PTH)和血清钙水平分别为996纳克/升和4.54毫摩尔/升。12例患者术前接受了超声检查。其中,6个腺体突出,而其他6个腺体未见。对15名患者进行了Sestamibi扫描,其中9人呈阴性,6人呈阳性,颈部有3个腺体,舌下有3个。19例患者接受了肾脏超声检查,其中9例显示肾钙化。手术时的平均年龄为5.2个月。17名患者进行了甲状旁腺全切除术(4个腺体),15名患者同时进行了自体移植。一名患者除自体移植外,还切除了三个腺体。另一位接受了单腺切除术,作为之前在其他地方手术后的重做手术。术后平均随访时间为6年。术后PTH和钙的平均水平分别为25 ng/L和1.64 mmol/L。最终,除了两名接受了自体移植的患者外,所有患者都被要求开始补充钙和维生素D。钙敏感受体基因的分子遗传学筛查报告了19例患者中16例可能的致病性/致病性突变(13例为纯合子,2例为杂合子,1例为阴性,其余3例患者的数据不可用)。结论:NSHPT的手术治疗是有效的。术前放射学定位研究并未影响治疗计划。事实证明,自体移植在维持对药物补充剂的独立性方面是无效的。局限性:该研究的回顾性可能意味着不准确,但由于数据是从电子医疗记录中收集的,我们相信它是高度准确的。样本量小限制了可推广性。
{"title":"Surgical management of neonatal severe hyperparathyroidism.","authors":"Saud Alshanafey, Sabreen Maqbol, Ali AlAmeer, Faiqa Ahmad, Abdullah Al-Ashwal","doi":"10.5144/0256-4947.2023.01.11.1200","DOIUrl":"10.5144/0256-4947.2023.01.11.1200","url":null,"abstract":"<p><strong>Background: </strong>Neonatal severe hyperparathyroidism (NSHPT) is a rare disease that can be lethal. Most patients require parathyroidectomy.</p><p><strong>Objective: </strong>Report experience in managing this severe disease.</p><p><strong>Design: </strong>Retrospective chart review of case series.</p><p><strong>Setting: </strong>Tertiary health care center.</p><p><strong>Patients and methods: </strong>We reviewed data on patients managed for NSHPT from June 2001 to January 2023. Demographic, clinical, and follow-up data were collected, and descriptive data were generated.</p><p><strong>Main outcome measures: </strong>Pre- and postoperative levels of parathyroid hormone (PTH) and serum calcium, and effect of autotransplantation.</p><p><strong>Sample size: </strong>19.</p><p><strong>Results: </strong>The 13 males and 6 females had a a mean age of 46 days at referral. The mean preoperative parathyroid hormone (PTH) and serum calcium levels were 996 ng/L and 4.54 mmol/L, respectively. Twelve patients underwent ultrasonography preoperatively. Of these, six had prominent glands, while no glands were seen in the other six. A Sestamibi scan was done for 15 patients, of which nine showed negative results and six showed positive results, with three glands observed in the neck and three in the sublingual area. Nineteen patients underwent renal ultrasonography, with nine showing nephrocalcinosis. The mean age at surgery was 5.2 months. Total parathyroidectomy (four glands) was performed in 17 patients, and 15 underwent concurrent auto-transplantation. One patient had three glands removed, in addition to auto-transplantation. Another underwent single gland excision as a redo-surgery after previous surgery elsewhere. The mean postoperative follow-up duration was 6 years. The mean postoperative PTH and calcium levels were 25 ng/L and 1.64 mmol/L, respectively. Ultimately, all the patients were required to initiate calcium and vitamin D supplements, except for two patients who had undergone auto-transplantation. Molecular genetic screening of the calcium-sensing receptor gene reported likely pathogenic/pathogenic mutations in 16 of 19 patients (13 were homozygous, two were heterozygous, one was negative, and data was unavailable for the remaining three patients).</p><p><strong>Conclusions: </strong>Surgical treatment of NSHPT is effective. Preoperative radiological localization studies did not impact the treatment plan. Auto-transplantation proved ineffective in maintaining independence from medical supplements.</p><p><strong>Limitations: </strong>The retrospective nature of the study may imply inaccuracybut since the data are gathered from electronic medical records, we believe it is highly accurate. The small sample size limits generalizability.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71430068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality outcomes between pregnant women booked for antenatal care and unbooked pregnant women. 预约产前检查的孕妇与未预约产前检查的孕妇的死亡率。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.357
Abdulrahim Rouzi, Nora Sahly, Abdullah Mohammed Kafy, Rana A Alamoudi, Renad Mazen Abualsaud, Wejdan A Alsheri, Wasayf M Almehmadi, Shahad T Khayyat, Razan M Altumaihi

Background: Perinatal fetal mortality and maternal mortality remains relatively high in Saudi Arabia. Antenatal care aims to improve outcomes; however, evidence to demonstrate its impact on outcomes in Saudi Arabia is lacking.

Objectives: Investigate whether booking status for antenatal care impacted outcomes for pregnant women and identify outcomes that predicted booking status.

Design: Retrospective observational cohort study.

Settings: Tertiary care center.

Patients and methods: All Saudi women admitted to the labor or delivery units between January 2011 and December 2019 were included. Outcomes were compared between booked and unbooked women, and logistic regression was used to identify outcomes that predicted booking status, adjusted for age.

Main outcome measures: Booked/unbooked status and perinatal mortality of Saudi women.

Sample size: 10 781 women; 9546 (88.5%) booked, (11.1%) 1192 unbooked.

Results: Unbooked mothers had higher incidences of meconium-stained liquor (P=.040), ruptured uterus (P=.017), and blood loss >1000 mL during cesarean deliveries (P=.003), but a lower episiotomy rate (P<.001). Perinatal fetal mortality and maternal mortality were equivalent between the two groups. Episiotomy, higher birth weight, higher mother age, perinatal death, delivery mode, onset of labor, and use of analgesics were all independent predictors of the mother being booked when adjusted for all outcomes and age.

Conclusions: The rate of perinatal and maternal mortality in this cohort was relatively low and equivalent between booked and un-booked mothers, contrary to our expectations. More analysis of the socioeconomic data may explain this striking result.

Limitations: Retrospective chart-review with incomplete data retrieval that affected the completeness of data retrieved. The results of the multivariate analysis cannot be used to infer causality because the study is observational.

背景:在沙特阿拉伯,围产期胎儿死亡率和孕产妇死亡率仍然相对较高。产前护理的目的是改善预后;然而,在沙特阿拉伯,缺乏证据证明产前护理对预后的影响:调查产前检查的预约情况是否会影响孕妇的预后,并确定可预测预约情况的预后:设计:回顾性观察队列研究:设置:三级医疗中心:纳入 2011 年 1 月至 2019 年 12 月期间入住产房或分娩室的所有沙特籍孕妇。对已预约和未预约产妇的结果进行比较,并使用逻辑回归确定预测预约状态的结果,同时对年龄进行调整:样本量:10 781 名妇女;其中 9546 人(88.5%)已预约,1192 人(11.1%)未预约:结果:未预约产妇的胎粪染色液(P=.040)、子宫破裂(P=.017)和剖宫产失血量大于 1000 毫升(P=.003)的发生率较高,但外阴切开术的发生率较低(PConclusions:该队列中围产期和孕产妇死亡率相对较低,预约和未预约产妇的死亡率相当,这与我们的预期相反。对社会经济数据的更多分析可能会解释这一惊人的结果:回顾性图表审查,数据检索不完整,影响了数据检索的完整性。多变量分析的结果不能用来推断因果关系,因为该研究是观察性的。
{"title":"Mortality outcomes between pregnant women booked for antenatal care and unbooked pregnant women.","authors":"Abdulrahim Rouzi, Nora Sahly, Abdullah Mohammed Kafy, Rana A Alamoudi, Renad Mazen Abualsaud, Wejdan A Alsheri, Wasayf M Almehmadi, Shahad T Khayyat, Razan M Altumaihi","doi":"10.5144/0256-4947.2023.357","DOIUrl":"10.5144/0256-4947.2023.357","url":null,"abstract":"<p><strong>Background: </strong>Perinatal fetal mortality and maternal mortality remains relatively high in Saudi Arabia. Antenatal care aims to improve outcomes; however, evidence to demonstrate its impact on outcomes in Saudi Arabia is lacking.</p><p><strong>Objectives: </strong>Investigate whether booking status for antenatal care impacted outcomes for pregnant women and identify outcomes that predicted booking status.</p><p><strong>Design: </strong>Retrospective observational cohort study.</p><p><strong>Settings: </strong>Tertiary care center.</p><p><strong>Patients and methods: </strong>All Saudi women admitted to the labor or delivery units between January 2011 and December 2019 were included. Outcomes were compared between booked and unbooked women, and logistic regression was used to identify outcomes that predicted booking status, adjusted for age.</p><p><strong>Main outcome measures: </strong>Booked/unbooked status and perinatal mortality of Saudi women.</p><p><strong>Sample size: </strong>10 781 women; 9546 (88.5%) booked, (11.1%) 1192 unbooked.</p><p><strong>Results: </strong>Unbooked mothers had higher incidences of meconium-stained liquor (<i>P</i>=.040), ruptured uterus (<i>P</i>=.017), and blood loss >1000 mL during cesarean deliveries (<i>P</i>=.003), but a lower episiotomy rate (<i>P</i><.001). Perinatal fetal mortality and maternal mortality were equivalent between the two groups. Episiotomy, higher birth weight, higher mother age, perinatal death, delivery mode, onset of labor, and use of analgesics were all independent predictors of the mother being booked when adjusted for all outcomes and age.</p><p><strong>Conclusions: </strong>The rate of perinatal and maternal mortality in this cohort was relatively low and equivalent between booked and un-booked mothers, contrary to our expectations. More analysis of the socioeconomic data may explain this striking result.</p><p><strong>Limitations: </strong>Retrospective chart-review with incomplete data retrieval that affected the completeness of data retrieved. The results of the multivariate analysis cannot be used to infer causality because the study is observational.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rebound pain after interscalene brachial plexus block for shoulder surgery: a randomized clinical trial of the effect of different multimodal analgesia regimens. 肩部手术椎间臂丛阻滞术后的反跳痛:不同多模式镇痛方案效果的随机临床试验。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.339
Tayfun Et, Betul Basaran, Aysegul Bilge, Rafet Yarımoğlu, Muhammet Korkusuz, İbrahim Tülüce

Background: Rebound pain is characterized by sudden, significant acute postoperative pain occurring after the resolution of inter-scalene block (ISB); it affects the quality of recovery postoperatively. Dexamethasone increases ISB resolution time and decreases opioid consumption and the incidence of rebound pain.

Objective: Evaluate whether multimodal analgesia including intravenous dexamethasone administration with preoperative ISB reduces the incidence of rebound pain.

Design: Prospective, randomized, controlled trial.

Setting: Tertiary university hospital.

Sample size: 60 patients.

Patients and methods: Patients who underwent shoulder surgery under general anesthesia were assigned randomly to two different multimodal analgesia protocols. Thirty patients received 5 mg IV dexamethasone with non-steroid, paracetamol, and ISB with 15 mL 0.5% bupivacaine, while the control patients received the same regimen and ISB with 15 mL 0.5% bupivacaine without dexamethasone. Postoperative opioids were given to any patient on demand.

Main outcomes measures: Effect of IV dexamethasone on pain score and incidence of rebound pain after ISB resolution and postoperative opioid consumption at 0-48 hours, numerical pain rating scale (NPRS) scores, sleep scale scores, and quality of recovery-15 scores (QoR-15).

Results: The incidence of rebound pain was lower in the dexamethasone group than in the control group (73.3% and 30%, respectively, P=.001). NPRS scores after ISB resolution were lower in the dexamethasone group (5 ([4-7]), 8 ([5.75-8]), P<.001, respectively). Those who received IV dexamethasone had less sleep disturbances (P<.001) and higher QoR-15 on day 1 (P<.001) and day 7 (P=.020) postoperatively.

Conclusions: IV dexamethasone added to the ISB block resulted in a lower incidence of rebound pain. In addition, better results were obtained in postoperative sleep quality and QoR-15.

Limitations: Single-center study.

背景:反跳痛的特点是在肩胛间阻滞(ISB)缓解后突然发生的、明显的术后急性疼痛;它影响术后恢复的质量。地塞米松能延长ISB解除时间,减少阿片类药物的用量和反跳痛的发生率:评估包括术前 ISB 时静脉注射地塞米松在内的多模式镇痛是否能降低反跳痛的发生率:设计:前瞻性、随机对照试验:样本量:60 例患者:在全身麻醉下接受肩部手术的患者被随机分配到两种不同的多模式镇痛方案中。30名患者接受5毫克地塞米松静脉注射,同时使用非甾体类药物扑热息痛和15毫升0.5%布比卡因进行ISB,而对照组患者接受相同的方案,同时使用15毫升0.5%布比卡因进行ISB,不使用地塞米松。术后阿片类药物按需提供给任何患者:主要结果指标:静脉注射地塞米松对ISB缓解后疼痛评分和反跳痛发生率的影响、术后0-48小时阿片类药物用量、疼痛评分量表(NPRS)评分、睡眠评分量表评分和恢复质量-15评分(QoR-15):地塞米松组的反跳痛发生率低于对照组(分别为73.3%和30%,P=.001)。地塞米松组术后ISB缓解后的NPRS评分较低(5([4-7]),8([5.75-8]),PPPP=.020):结论:在 ISB 阻滞中加入静脉注射地塞米松可降低反跳痛的发生率。此外,术后睡眠质量和 QoR-15 也得到了改善:局限性:单中心研究。
{"title":"Rebound pain after interscalene brachial plexus block for shoulder surgery: a randomized clinical trial of the effect of different multimodal analgesia regimens.","authors":"Tayfun Et, Betul Basaran, Aysegul Bilge, Rafet Yarımoğlu, Muhammet Korkusuz, İbrahim Tülüce","doi":"10.5144/0256-4947.2023.339","DOIUrl":"10.5144/0256-4947.2023.339","url":null,"abstract":"<p><strong>Background: </strong>Rebound pain is characterized by sudden, significant acute postoperative pain occurring after the resolution of inter-scalene block (ISB); it affects the quality of recovery postoperatively. Dexamethasone increases ISB resolution time and decreases opioid consumption and the incidence of rebound pain.</p><p><strong>Objective: </strong>Evaluate whether multimodal analgesia including intravenous dexamethasone administration with preoperative ISB reduces the incidence of rebound pain.</p><p><strong>Design: </strong>Prospective, randomized, controlled trial.</p><p><strong>Setting: </strong>Tertiary university hospital.</p><p><strong>Sample size: </strong>60 patients.</p><p><strong>Patients and methods: </strong>Patients who underwent shoulder surgery under general anesthesia were assigned randomly to two different multimodal analgesia protocols. Thirty patients received 5 mg IV dexamethasone with non-steroid, paracetamol, and ISB with 15 mL 0.5% bupivacaine, while the control patients received the same regimen and ISB with 15 mL 0.5% bupivacaine without dexamethasone. Postoperative opioids were given to any patient on demand.</p><p><strong>Main outcomes measures: </strong>Effect of IV dexamethasone on pain score and incidence of rebound pain after ISB resolution and postoperative opioid consumption at 0-48 hours, numerical pain rating scale (NPRS) scores, sleep scale scores, and quality of recovery-15 scores (QoR-15).</p><p><strong>Results: </strong>The incidence of rebound pain was lower in the dexamethasone group than in the control group (73.3% and 30%, respectively, <i>P</i>=.001). NPRS scores after ISB resolution were lower in the dexamethasone group (5 ([4-7]), 8 ([5.75-8]), <i>P</i><.001, respectively). Those who received IV dexamethasone had less sleep disturbances (<i>P</i><.001) and higher QoR-15 on day 1 (<i>P</i><.001) and day 7 (<i>P</i>=.020) postoperatively.</p><p><strong>Conclusions: </strong>IV dexamethasone added to the ISB block resulted in a lower incidence of rebound pain. In addition, better results were obtained in postoperative sleep quality and QoR-15.</p><p><strong>Limitations: </strong>Single-center study.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transanal minimally invasive surgery for benign and malignant rectal lesions: midterm outcomes from a tertiary center. 经肛门微创手术治疗直肠良性和恶性病变:一家三级医疗中心的中期疗效。
Pub Date : 2023-11-01 Epub Date: 2023-12-07 DOI: 10.5144/0256-4947.2023.348
Mahmood Al-Dhaheri, Fajer Al-Ishaq, Ali Toffaha, Mohamed Abu Nada, Amjad Parvaiz, Mohamed Kurer

Background: Although transanal minimally invasive surgery (TAMIS) for rectal neoplasia has gained wide acceptance, the mid-term and long-term outcomes are not widely reported in the literature.

Objective: Describe the mid-term outcomes of patients who underwent TAMIS for benign and malignant rectal lesions in a single center.

Design: Retrospective cohort study.

Settings: Tertiary referral center.

Patients and methods: Demographic, clinical, and oncological outcomes of patients who underwent TAMIS between January 2015 and December 2022 were prospectively collected. The indication for TAMIS was based on the National Comprehensive Cancer Network guidelines. The follow up for the cancer patients included clinical examination, tumor markers every 6 months and MRI rectum at the end of one year. In addition, colonoscopy and CT scan at years one and three and a final CT scan and colonoscopy at year five.

Main outcome measures: Mid-term oncological and clinical outcome.

Results: Thirty elective TAMIS procedures included adenocarcinoma for 33.3% (n=10) of the patients, 20% (n=6) neuroendocrine tumor and the 40% (n=12) were adenomatous lesions. Negative resection margins were achieved in all malignant lesions. Perioperative complications occurred in 2 patients (6.6%), one patient had breaching into the peritoneal cavity, and postoperative hypotension occurred in another patient. The median follow-up time was 23 months (range: 5-72 months). Two patients with adenoma and positive margins developed recurrent adenoma (6.6%) and one patient with initial polypectomy biopsy of adenocarcinoma, had TAMIS with histopathology of adenoma and distant metastasis had developed.

Conclusions: TAMIS for local excision of rectal neoplasia is a valid option with favorable mid-term outcomes provided there is adherence to careful selection criteria.

Limitations: Retrospective nature and small number of the patients.

背景:尽管经肛门微创手术(TAMIS)治疗直肠肿瘤已被广泛接受,但中期和长期疗效的文献报道并不多:描述在一个中心接受经肛门微创手术治疗直肠良性和恶性病变患者的中期疗效:设计:回顾性队列研究:设置:三级转诊中心:前瞻性地收集了2015年1月至2022年12月期间接受TAMIS的患者的人口统计学、临床和肿瘤学结果。TAMIS的适应症基于美国国家综合癌症网络指南。癌症患者的随访包括临床检查、每6个月一次的肿瘤标志物检查和一年后的直肠核磁共振检查。此外,第一和第三年进行结肠镜检查和 CT 扫描,第五年进行最后一次 CT 扫描和结肠镜检查:结果:30例选择性TAMIS手术患者中,33.3%(10例)为腺癌,20%(6例)为神经内分泌肿瘤,40%(12例)为腺瘤性病变。所有恶性病变的切除边缘均为阴性。2名患者(6.6%)出现了围手术期并发症,其中一名患者的肿瘤破入腹腔,另一名患者出现了术后低血压。中位随访时间为 23 个月(5-72 个月)。两名腺瘤和边缘阳性的患者出现了腺瘤复发(6.6%),一名患者最初的息肉切除活检结果为腺癌,但在接受 TAMIS 治疗后,组织病理学检查结果为腺瘤,并出现了远处转移:结论:TAMIS用于直肠肿瘤局部切除术是一种有效的选择,只要严格遵守选择标准,中期疗效良好:局限性:具有回顾性,患者人数较少。
{"title":"Transanal minimally invasive surgery for benign and malignant rectal lesions: midterm outcomes from a tertiary center.","authors":"Mahmood Al-Dhaheri, Fajer Al-Ishaq, Ali Toffaha, Mohamed Abu Nada, Amjad Parvaiz, Mohamed Kurer","doi":"10.5144/0256-4947.2023.348","DOIUrl":"10.5144/0256-4947.2023.348","url":null,"abstract":"<p><strong>Background: </strong>Although transanal minimally invasive surgery (TAMIS) for rectal neoplasia has gained wide acceptance, the mid-term and long-term outcomes are not widely reported in the literature.</p><p><strong>Objective: </strong>Describe the mid-term outcomes of patients who underwent TAMIS for benign and malignant rectal lesions in a single center.</p><p><strong>Design: </strong>Retrospective cohort study.</p><p><strong>Settings: </strong>Tertiary referral center.</p><p><strong>Patients and methods: </strong>Demographic, clinical, and oncological outcomes of patients who underwent TAMIS between January 2015 and December 2022 were prospectively collected. The indication for TAMIS was based on the National Comprehensive Cancer Network guidelines. The follow up for the cancer patients included clinical examination, tumor markers every 6 months and MRI rectum at the end of one year. In addition, colonoscopy and CT scan at years one and three and a final CT scan and colonoscopy at year five.</p><p><strong>Main outcome measures: </strong>Mid-term oncological and clinical outcome.</p><p><strong>Results: </strong>Thirty elective TAMIS procedures included adenocarcinoma for 33.3% (n=10) of the patients, 20% (n=6) neuroendocrine tumor and the 40% (n=12) were adenomatous lesions. Negative resection margins were achieved in all malignant lesions. Perioperative complications occurred in 2 patients (6.6%), one patient had breaching into the peritoneal cavity, and postoperative hypotension occurred in another patient. The median follow-up time was 23 months (range: 5-72 months). Two patients with adenoma and positive margins developed recurrent adenoma (6.6%) and one patient with initial polypectomy biopsy of adenocarcinoma, had TAMIS with histopathology of adenoma and distant metastasis had developed.</p><p><strong>Conclusions: </strong>TAMIS for local excision of rectal neoplasia is a valid option with favorable mid-term outcomes provided there is adherence to careful selection criteria.</p><p><strong>Limitations: </strong>Retrospective nature and small number of the patients.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11182431/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selective anterior annuloplasty during inguinal herniotomy in boys: an approach to further reduce hernia recurrence. 男孩腹股沟疝切开术中选择性前瓣环成形术:一种进一步减少疝复发的方法。
Pub Date : 2023-09-01 Epub Date: 2023-10-05 DOI: 10.5144/0256-4947.2023.277
Ayman Aljazaeri, Raghad AlKhashan, Razan Naif AlRabah, Sadem Al Zayed, Sara Al-Jazaeri

Background: Hernia recurrence is one of the most common complications after inguinal herniotomy (IH) in children. We describe a novel approach that involves adding anterior annuloplasty (AAP) during IH for selective high recurrence-risk children.

Objectives: Evaluate the initial safety and effectiveness of selective AAP during IH in boys.

Design: Retrospective SETTING: Tertiary care center.

Patients and methods: The study included boys younger than 15 who were selected to undergo either IH with or without AAP between January 2011 and January 2022. The preoperative recurrence risks were compared for the two groups. Cases who underwent other forms of hernia repair were excluded.

Main outcome measures: The frequency of recurrence and other postoperative complications and the distribution of high recurrence-risks.

Sample size: 315 boys; 143 underwent IH and AAP, while 172 had IH only.

Results: Among all the cases, only one recurrence was reported (0.3%). Other complications were hydrocele in 29 (9.2%), scrotal hematoma/inflammation in 9 (2.9%), and wound infection in 8 (2.6%), which resolved spontaneously in all cases. Compared to IH only, those selected for an additional AAP were significantly younger (3 [16%] vs. 12 [46%] months, P=.038) and more likely to be premature (35 [24.5%] vs. 15 [8.7%], P<.0001), frequently had extensive cremasteric adhesions (39.2% versus 3.5%, P<.0001) and had a higher rate of incarcerated hernia at presentation (6.3% versus 1.2%, P=.026). The high-recurrence risk group was almost twice as likely to be selected for an additional AAP compared to the low-risk group (143 vs. 75, P<.0001).

Conclusion: Adding simple AAP to conventional hernia repair for high-recurrence risk boys can be a safe and effective step to reduce the overall risk of recurrence without increasing the incidence of other postoperative complications.

Limitations: The study lacked a control group of patients to whom selective AAP would not be offered despite a high-recurrence risk. A prospective, controlled trial with a longer follow-up would lead to a stronger conclusion.

背景:疝复发是儿童腹股沟疝切开术后最常见的并发症之一。我们描述了一种新的方法,包括在选择性高复发风险儿童的IH期间增加前瓣环成形术(AAP)。目的:评估男孩IH期间选择性AAP的初步安全性和有效性。设计:回顾性设置:三级护理中心。患者和方法:该研究包括年龄在15岁以下的男孩,他们被选择在2011年1月至2022年1月期间接受有或无AAP的IH。比较两组患者术前复发的风险。排除了接受其他形式疝修补术的病例。主要结果指标:复发和其他术后并发症的频率以及高复发风险的分布。样本量:315名男孩;143人接受了IH和AAP,172人只接受了IH。结果:在所有病例中,只有一例复发(0.3%),其他并发症为鞘膜积液29例(9.2%),阴囊血肿/炎症9例(2.9%),伤口感染8例(2.6%),所有病例均自发消退。与仅IH相比,那些选择额外AAP的患者明显更年轻(3个月[16%]对12个月[46%],P=0.038),更有可能早产(35个月[24.5%]对15个月[8.7%],PPP=.026)。与低风险组相比,高复发风险组选择额外AAP的可能性几乎是低风险组的两倍(143 vs.75,P结论:在高复发风险男孩的常规疝修补术中加入简单的AAP是一个安全有效的步骤,可以在不增加其他术后并发症发生率的情况下降低复发的总体风险。局限性:该研究缺乏一个对照组,尽管复发风险很高,但不会对其提供选择性AAP随访时间较长的对照试验将得出更有力的结论。
{"title":"Selective anterior annuloplasty during inguinal herniotomy in boys: an approach to further reduce hernia recurrence.","authors":"Ayman Aljazaeri, Raghad AlKhashan, Razan Naif AlRabah, Sadem Al Zayed, Sara Al-Jazaeri","doi":"10.5144/0256-4947.2023.277","DOIUrl":"10.5144/0256-4947.2023.277","url":null,"abstract":"<p><strong>Background: </strong>Hernia recurrence is one of the most common complications after inguinal herniotomy (IH) in children. We describe a novel approach that involves adding anterior annuloplasty (AAP) during IH for selective high recurrence-risk children.</p><p><strong>Objectives: </strong>Evaluate the initial safety and effectiveness of selective AAP during IH in boys.</p><p><strong>Design: </strong>Retrospective SETTING: Tertiary care center.</p><p><strong>Patients and methods: </strong>The study included boys younger than 15 who were selected to undergo either IH with or without AAP between January 2011 and January 2022. The preoperative recurrence risks were compared for the two groups. Cases who underwent other forms of hernia repair were excluded.</p><p><strong>Main outcome measures: </strong>The frequency of recurrence and other postoperative complications and the distribution of high recurrence-risks.</p><p><strong>Sample size: </strong>315 boys; 143 underwent IH and AAP, while 172 had IH only.</p><p><strong>Results: </strong>Among all the cases, only one recurrence was reported (0.3%). Other complications were hydrocele in 29 (9.2%), scrotal hematoma/inflammation in 9 (2.9%), and wound infection in 8 (2.6%), which resolved spontaneously in all cases. Compared to IH only, those selected for an additional AAP were significantly younger (3 [16%] vs. 12 [46%] months, <i>P</i>=.038) and more likely to be premature (35 [24.5%] vs. 15 [8.7%], <i>P</i><.0001), frequently had extensive cremasteric adhesions (39.2% versus 3.5%, <i>P</i><.0001) and had a higher rate of incarcerated hernia at presentation (6.3% versus 1.2%, <i>P</i>=.026). The high-recurrence risk group was almost twice as likely to be selected for an additional AAP compared to the low-risk group (143 vs. 75, <i>P</i><.0001).</p><p><strong>Conclusion: </strong>Adding simple AAP to conventional hernia repair for high-recurrence risk boys can be a safe and effective step to reduce the overall risk of recurrence without increasing the incidence of other postoperative complications.</p><p><strong>Limitations: </strong>The study lacked a control group of patients to whom selective AAP would not be offered despite a high-recurrence risk. A prospective, controlled trial with a longer follow-up would lead to a stronger conclusion.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/c2/0256-4947.2023.277.PMC10560372.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41157700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience with direct-acting antivirals in genotype 1-5 infected chronic hepatitis C patients in Turkey. 土耳其1-5型感染的慢性丙型肝炎患者使用直接作用抗病毒药物的经验。
Pub Date : 2023-09-01 Epub Date: 2023-10-05 DOI: 10.5144/0256-4947.2023.308
Ahmet Sahin, Ozlem Akay

Background: Hepatitis C virus (HCV) can cause chronic liver disease, hepatic cirrhosis, hepatocellular carcinoma, liver transplantation, and death. Early diagnosis and treatment are thus vital.

Objectives: We aimed to investigate the sustained virological response (SVR) rates in chronic hepatitis C patients infected with different genotypes, receiving different direct-acting antiviral treatments (DAAs).

Design: Retrospective, observational SETTING: Clinic for infectious diseases and clinical microbiology PATIENTS AND METHODS: Patients diagnosed with chronic hepatitis C who applied to our outpatient clinic between January 2016 and November 2022 and were treated with a DAA were included in the study. Treatment responses were evaluated after each patient was treated with either ledipasvir plus sofosbuvir (LDV/SOF), LDV/SOF + ribavirin (RBV), SOF+RBV, ombitasvir/paritaprevir/ritonavir plus dasabuvir (OBV/PTV/r±DSV) ±RBV, or glecaprevir plus pibrentasvir (GLE/PIB).

Main outcome measures: Sustained virological response (SVR) rates at 12 weeks (SVR12) post-treatment.

Sample size: 360 patients.

Results: Of 360 patients who met the inclusion criteria, 218 (60.6%) were male and 142 (39.4%) were female with no statistically significant differences in SVR between sexes (P=.252). Nearly all had a SVR (n=353, 98.1%). The median (IQR) age of the patients was 56 (30.3) years. There were 42 (11.7%), 199 (55.3%), 4 (1.1%), 106 (29.4%), 8 (2.2%) and 1 (0.3%) patient with genotypes 1a, 1b, 2, 3, 4 and 5, respectively, and SVR12 did not differ significantly between genotypes (P=.066). SVR12 response was higher in 246 (68.3%) non-injecting drug users compared to 114 (31.7%) injecting drug users (P=.005). The SVR12 response was achieved in 100% of patients with genotypes 1a, 2, 4, and 5. SVR12 response could not be obtained in 1 of 199 genotype 1b patients and 6 of 106 genotype 3 patients. The common feature of 6 reinfection patients with genotype 3 was that they were using intravenous drugs. These 6 patients were reinfected due to their continued intravenous drug use.

Conclusion: In conclusion, DAAs provide high SVR12 rates in cirrhotic/non-cirrhotic, pegylated interferon-naive/experienced patient groups and in patients infected with all genotypes. DAAs have a high SVR12 rate in patients with chronic hepatitis C.

Limitations: Retrospective, single-center.

背景:丙型肝炎病毒(HCV)可引起慢性肝病、肝硬化、肝细胞癌、肝移植和死亡。因此,早期诊断和治疗至关重要。目的:我们旨在研究不同基因型感染的慢性丙型肝炎患者接受不同直接作用抗病毒治疗(DAAs)的持续病毒学应答(SVR)率,观察环境:传染病和临床微生物学诊所患者和方法:2016年1月至2022年11月期间申请我们门诊并接受DAA治疗的被诊断为慢性丙型肝炎的患者被纳入研究。在每位患者接受乐迪帕韦加索非布韦(LDV/SOF)、LDV/SOF+利巴韦林(RBV)、SOF+RBV、奥比他韦/帕利他韦/利托那韦加达沙布韦(OBV/PTV/r±DSV)±RBV或格列卡韦加皮布伦他韦(GLE/PIB)治疗后,评估治疗反应。主要结果指标:治疗后12周的持续病毒学反应(SVR)率(SVR12)。样本量:360名患者。结果:在符合纳入标准的360名患者中,218名(60.6%)为男性,142名(39.4%)为女性,性别间SVR无统计学显著差异(P=.252)。几乎所有患者都有SVR(n=353,98.1%)。患者的中位(IQR)年龄为56(30.3)岁。基因型1a、1b、2、3、4和5的患者分别为42例(11.7%)、199例(55.3%)、4例(1.1%)、106例(29.4%)、8例(2.2%)和1例(0.3%),不同基因型的SVR12无显著差异(P=.066),2、4和5。199例基因型1b患者中有1例和106例基因型3患者中有6例不能获得SVR12应答。6例基因型为3的再次感染患者的共同特征是他们正在使用静脉注射药物。这6名患者因持续静脉注射药物而再次感染。结论:总之,DAAs在肝硬化/非肝硬化、聚乙二醇干扰素初始/经验丰富的患者组以及所有基因型感染的患者中提供了高SVR12率。DAA在慢性丙型肝炎患者中具有较高的SVR12比率。局限性:回顾性,单中心。
{"title":"Experience with direct-acting antivirals in genotype 1-5 infected chronic hepatitis C patients in Turkey.","authors":"Ahmet Sahin,&nbsp;Ozlem Akay","doi":"10.5144/0256-4947.2023.308","DOIUrl":"10.5144/0256-4947.2023.308","url":null,"abstract":"<p><strong>Background: </strong>Hepatitis C virus (HCV) can cause chronic liver disease, hepatic cirrhosis, hepatocellular carcinoma, liver transplantation, and death. Early diagnosis and treatment are thus vital.</p><p><strong>Objectives: </strong>We aimed to investigate the sustained virological response (SVR) rates in chronic hepatitis C patients infected with different genotypes, receiving different direct-acting antiviral treatments (DAAs).</p><p><strong>Design: </strong>Retrospective, observational SETTING: Clinic for infectious diseases and clinical microbiology PATIENTS AND METHODS: Patients diagnosed with chronic hepatitis C who applied to our outpatient clinic between January 2016 and November 2022 and were treated with a DAA were included in the study. Treatment responses were evaluated after each patient was treated with either ledipasvir plus sofosbuvir (LDV/SOF), LDV/SOF + ribavirin (RBV), SOF+RBV, ombitasvir/paritaprevir/ritonavir plus dasabuvir (OBV/PTV/r±DSV) ±RBV, or glecaprevir plus pibrentasvir (GLE/PIB).</p><p><strong>Main outcome measures: </strong>Sustained virological response (SVR) rates at 12 weeks (SVR12) post-treatment.</p><p><strong>Sample size: </strong>360 patients.</p><p><strong>Results: </strong>Of 360 patients who met the inclusion criteria, 218 (60.6%) were male and 142 (39.4%) were female with no statistically significant differences in SVR between sexes (<i>P</i>=.252). Nearly all had a SVR (n=353, 98.1%). The median (IQR) age of the patients was 56 (30.3) years. There were 42 (11.7%), 199 (55.3%), 4 (1.1%), 106 (29.4%), 8 (2.2%) and 1 (0.3%) patient with genotypes 1a, 1b, 2, 3, 4 and 5, respectively, and SVR12 did not differ significantly between genotypes (<i>P</i>=.066). SVR12 response was higher in 246 (68.3%) non-injecting drug users compared to 114 (31.7%) injecting drug users (<i>P</i>=.005). The SVR12 response was achieved in 100% of patients with genotypes 1a, 2, 4, and 5. SVR12 response could not be obtained in 1 of 199 genotype 1b patients and 6 of 106 genotype 3 patients. The common feature of 6 reinfection patients with genotype 3 was that they were using intravenous drugs. These 6 patients were reinfected due to their continued intravenous drug use.</p><p><strong>Conclusion: </strong>In conclusion, DAAs provide high SVR12 rates in cirrhotic/non-cirrhotic, pegylated interferon-naive/experienced patient groups and in patients infected with all genotypes. DAAs have a high SVR12 rate in patients with chronic hepatitis C.</p><p><strong>Limitations: </strong>Retrospective, single-center.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b2/03/0256-4947.2023.308.PMC10560371.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41124030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Saudi medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1